Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 2/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | CTSA | P10619 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30954060 | 1.00 | KDM4E (0.33) | KDM4EALDH1A1HSD17B10PTGDR2ACACB | |
| SCHEMBL27434615 | 0.91 | ACACB (0.32) | KDM4EHSD17B10PTGDR2ACACBDRD3 | |
| SCHEMBL30954041 | 0.82 | CYP3A4 (0.38) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL27435450 | 0.82 | CYP3A4 (0.38) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL27435528 | 0.82 | KCNA3 (0.41) | KDM4EALDH1A1HSD17B10ACACBDRD3 | |
| SCHEMBL27435335 | 0.81 | KDM4E (0.40) | KDM4EALDH1A1HSD17B10DRD3 | |
| SCHEMBL30954160 | 0.81 | KDM4E (0.40) | KDM4EALDH1A1HSD17B10DRD3 | |
| SCHEMBL30954067 | 0.80 | TP53 (0.42) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL27435254 | 0.80 | TP53 (0.42) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL30954045 | 0.78 | POLB (0.42) | KDM4EALDH1A1HSD17B10DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | claimed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |